Table 1.
Antipsychotic | No. Patients Died/Total (%) | Total Person-years | Mortality Rate per 100 Person-years (95% CI) |
---|---|---|---|
Intention-to-treat analysis | |||
Haloperidol | 60/282 (21.3) | 122.5 | 49.0 (37.4–63.0) |
Other typical AP | 20/140 (14.3) | 64.0 | 31.3 (19.1–48.3) |
Olanzapine | 113/837 (13.5) | 386.3 | 29.3 (24.1–35.2) |
Quetiapine fumarate | 462/5270 (8.8) | 2488.8 | 18.6 (16.9–20.3) |
Risperidone | 164/1155 (14.2) | 529.5 | 31.0 (26.4–36.1) |
Other atypical AP | 13/193 (6.7) | 91.3 | 14.2 (7.6–24.3) |
Exposure-only analysis | |||
Haloperidol | 35/282 (12.4) | 68.7 | 50.9 (35.5–70.9) |
Other typical AP | 8/140 (5.7) | 32.5 | 24.6 (10.6–48.5) |
Olanzapine | 54/837 (6.5) | 240.1 | 22.5 (16.9–29.3) |
Quetiapine | 268/5270 (5.1) | 1754.2 | 15.3 (13.5–17.2) |
Risperidone | 96/1155 (8.3) | 340.8 | 28.2 (22.8–34.4) |
Other atypical AP | 7/193 (3.6) | 59.1 | 11.8 (4.8–24.4) |
Abbreviation: AP, antipsychotic.